According to the SEC filing dated August 15, 2018, John Paulson’s Paulson & Co. invested  $948 million on Allergan, Inc. (NYSE:AGN) as of end of the second quarter 2014. According to the filing, Paulson bought 5.6 million shares of Allergan, Inc. (NYSE:AGN) in the second quarter.

Argan, Inc. (NYSE:AGN) is a multi-specialty health care company which is operating worldwide. The company has a P/E ratio of 38 and dividend yield of 0.1%.

Samuel Isaly’s Orbimed Advisors and Jonathon Jacobson’s Highfields Capital Management are the other large shareholders of the company.

Click here to check the complete list of John Paulson holdings.